Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: Correlation with stroke severity

Hypertension Research

Volumn 31, Issue 9, 2008, Pages 1695-1702

  Tomita, Hirofumi ^a,b   Metoki, Norifumi ^a   Saitoh, Genta ^a   Ashitate, Toshihiro ^b   Echizen, Takashi ^b   Katoh, Chisato ^b   Fukuda, Michitaka ^a   Yasujima, Minoru ^b   Osanai, Tomohiro ^b   Okumura, Ken ^b  

^a Hirosaki Stroke Center   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Acute ischemic; Heart diseases; Natriuretic peptides; Stroke

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; AGED; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RATING SCALE;

EID: 55449119761     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1695     Document Type: Article

References (31)

1. Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
2. Yasue H, Yoshimura M, Sumida H, et al: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
3. Nakagawa O, Ogawa Y, Itoh H, et al: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280-1287.
4. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
5. Saper CB, Hurley KM, Moga MM, et al: Brain natriuretic peptides: differential localization of a new family of neuropeptides. Neurosci Lett 1989; 96: 29-34.
6. Brosnan MJ, Clark JS, Jeffs B, et al: Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 1999; 33: 290-297.
7. Etgen T, Baum H, Sander K, Sander D: Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 2005; 36: 270-275.
8. Nakagawa K, Yamaguchi T, Seida M, et al: Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 2005; 19: 157-164.
9. Sharma JC, Ananda K, Ross I, Hill R, Vassallo M: N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovasc Dis 2006; 15: 121-127.
10. Iltumur K, Karabulut A, Apak I, Aluclu U, Ariturk Z, Toprak N: Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J 2006; 151: 1115-1122.
11. Mukoyama M, Nakao K, Obata K, et al: Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991; 180: 431-436.
12. Nishikimi T, Yoshihara F, Morimoto A, et al: Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
13. Sutton TM, Stewart RA, Gerber IL, et al: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280-2287.
14. Silvet H, Young-Xu Y, Walleigh D, Ravid S: Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92: 1124-1127.
15. Diamond JA, Phillips RA: Hypertensive heart disease. Hypertens Res 2005; 28: 191-202.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
17. Brott T, Adams HP Jr, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
19. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
20. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
21. Goetze JP, Gore A, Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB: Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004; 18: 1928-1930.
22. Sabatine MS, Morrow DA, de Lemos JA, et al: Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988-1995.
23. Jiang C, Lu H, Vincent KA, et al: Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics 2002; 8: 23-24
24. Fukui S, Katoh H, Tsuzuki N, et al: Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage. J Clin Neurosci 2004; 11: 507-511.
25. Modrego PJ, Boned B, Berlanga JJ, Serrano M: Plasmatic B-Type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci 2008; 5: 18-23.
26. Persson L, Hardemark HG, Gustafsson J, et al: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911-918.
27. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956-1960.
28. Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
29. Omland T, Aakvaag A, Bonarjee VV, et al: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963-1969.
30. Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J: Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke 1986; 17: 387-390.
31. Ay H, Arsava EM, Saribas O: Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels. Stroke 2002; 33: 286-289.